Header Logo

Meenakshi Jolly

Concepts (302)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lupus Erythematosus, Systemic
77
2023
192
21.330
Why?
Quality of Life
41
2023
660
7.820
Why?
Surveys and Questionnaires
22
2023
1216
2.850
Why?
Severity of Illness Index
28
2020
992
2.470
Why?
Health Status
11
2018
228
2.430
Why?
Patient Reported Outcome Measures
11
2021
508
2.300
Why?
Psychometrics
16
2022
242
2.290
Why?
Rheumatology
6
2019
85
1.910
Why?
Adult
55
2022
8152
1.910
Why?
Body Image
6
2017
27
1.890
Why?
Self Report
8
2023
226
1.750
Why?
Female
66
2022
15793
1.690
Why?
Middle Aged
48
2021
9306
1.680
Why?
Humans
86
2023
28462
1.590
Why?
Reproducibility of Results
20
2022
726
1.460
Why?
Cross-Cultural Comparison
9
2022
39
1.430
Why?
Patient Outcome Assessment
3
2015
41
1.380
Why?
Hydroxychloroquine
3
2021
10
1.320
Why?
Male
49
2022
15367
1.300
Why?
Lupus Erythematosus, Discoid
3
2021
9
1.240
Why?
Antirheumatic Agents
3
2021
86
1.230
Why?
Rheumatologists
2
2018
15
1.180
Why?
Pain
7
2020
406
1.010
Why?
Cross-Sectional Studies
14
2021
939
1.000
Why?
Fatigue
4
2020
65
0.920
Why?
Lupus Erythematosus, Cutaneous
2
2014
5
0.890
Why?
Health Status Indicators
3
2014
75
0.870
Why?
Interferon-alpha
7
2014
32
0.790
Why?
Pneumococcal Infections
1
2021
7
0.770
Why?
Depression
4
2020
454
0.760
Why?
Quality of Health Care
3
2023
126
0.740
Why?
Antibodies, Antinuclear
5
2018
13
0.720
Why?
Sickness Impact Profile
4
2014
13
0.720
Why?
Pain Measurement
5
2019
473
0.720
Why?
Lupus Nephritis
2
2017
32
0.620
Why?
Outpatient Clinics, Hospital
1
2018
15
0.620
Why?
Delivery of Health Care, Integrated
1
2018
25
0.610
Why?
Quality Indicators, Health Care
1
2018
38
0.600
Why?
Academic Medical Centers
1
2019
137
0.580
Why?
Cost of Illness
2
2015
53
0.570
Why?
Young Adult
12
2020
2100
0.570
Why?
Factor Analysis, Statistical
7
2020
63
0.570
Why?
Sleep Wake Disorders
1
2019
130
0.570
Why?
Unnecessary Procedures
1
2017
30
0.550
Why?
Culture
2
2013
28
0.540
Why?
Physicians
3
2015
121
0.530
Why?
Tattooing
2
2007
3
0.530
Why?
Adolescent
11
2020
2324
0.530
Why?
Practice Patterns, Physicians'
1
2017
122
0.520
Why?
Canada
4
2018
51
0.510
Why?
Language
6
2022
69
0.500
Why?
Biological Products
1
2016
45
0.500
Why?
Linear Models
6
2018
255
0.480
Why?
Arthritis, Rheumatoid
4
2019
263
0.480
Why?
Immunoglobulin kappa-Chains
1
2014
2
0.460
Why?
Immunoglobulin lambda-Chains
1
2014
2
0.460
Why?
Interleukin-10
1
2014
20
0.460
Why?
United States
7
2018
2185
0.460
Why?
Interleukin-6
1
2014
79
0.450
Why?
Autoantibodies
8
2013
80
0.440
Why?
Posterior Leukoencephalopathy Syndrome
1
2013
9
0.440
Why?
Patient Education as Topic
1
2014
161
0.430
Why?
Treatment Outcome
10
2018
3619
0.430
Why?
Teaching
2
2019
61
0.420
Why?
Cultural Characteristics
1
2013
21
0.420
Why?
Dermatology
1
2012
6
0.410
Why?
Diagnostic Self Evaluation
1
2012
14
0.410
Why?
Hospitals, County
1
2012
3
0.410
Why?
Hospitals, University
1
2012
28
0.400
Why?
Longitudinal Studies
6
2020
1391
0.400
Why?
Caregivers
1
2015
203
0.400
Why?
Adaptation, Psychological
5
2016
183
0.400
Why?
Body Dysmorphic Disorders
1
2011
2
0.390
Why?
Polymorphism, Single Nucleotide
8
2017
285
0.390
Why?
Emotions
3
2017
87
0.380
Why?
Immunoglobulin Light Chains
1
2011
6
0.380
Why?
Aged
10
2021
9339
0.350
Why?
Genetic Predisposition to Disease
6
2018
382
0.350
Why?
Benchmarking
1
2010
38
0.340
Why?
Demography
1
2010
75
0.340
Why?
Income
1
2010
78
0.330
Why?
Clinical Trials as Topic
4
2016
236
0.330
Why?
Cognitive Dysfunction
1
2019
1072
0.320
Why?
Predictive Value of Tests
4
2017
494
0.310
Why?
Activities of Daily Living
2
2012
612
0.310
Why?
Case-Control Studies
6
2014
600
0.310
Why?
Stress, Psychological
3
2020
243
0.300
Why?
Randomized Controlled Trials as Topic
3
2016
329
0.300
Why?
Paracentesis
1
2007
4
0.280
Why?
Vasculitis, Leukocytoclastic, Cutaneous
1
2007
2
0.280
Why?
Suction
1
2007
40
0.280
Why?
Genital Diseases, Female
1
2006
5
0.270
Why?
Reference Values
3
2014
199
0.270
Why?
Chronic Disease
2
2005
442
0.270
Why?
Hyperuricemia
1
2006
4
0.260
Why?
Takayasu Arteritis
1
2005
1
0.250
Why?
Uveitis
1
2005
10
0.250
Why?
Chicago
2
2018
941
0.250
Why?
Metabolic Syndrome
1
2006
62
0.250
Why?
Leukoencephalopathy, Progressive Multifocal
1
2007
113
0.250
Why?
Vasculitis
1
2005
29
0.250
Why?
Pre-Eclampsia
1
2004
7
0.240
Why?
Prognosis
3
2014
824
0.240
Why?
Chlamydia trachomatis
1
2004
6
0.230
Why?
Tumor Necrosis Factor-alpha
1
2005
192
0.230
Why?
Chlamydia Infections
1
2004
7
0.230
Why?
Heart Diseases
1
2005
68
0.230
Why?
Antibodies, Monoclonal
1
2005
199
0.230
Why?
Pregnancy Complications
1
2004
52
0.220
Why?
Depressive Disorder
2
2018
184
0.220
Why?
Translations
2
2013
12
0.220
Why?
Diagnosis, Differential
3
2013
371
0.210
Why?
Comorbidity
3
2013
502
0.210
Why?
Sex Factors
2
2018
480
0.200
Why?
Patient Acceptance of Health Care
1
2023
82
0.200
Why?
Cardiovascular Diseases
1
2006
373
0.200
Why?
Vaccination
1
2021
32
0.190
Why?
Immunocompromised Host
1
2021
45
0.190
Why?
Prospective Studies
3
2020
1810
0.180
Why?
Regression Analysis
3
2020
267
0.180
Why?
Autoimmunity
2
2010
13
0.170
Why?
Health Surveys
2
2017
92
0.170
Why?
Cohort Studies
6
2017
1948
0.170
Why?
Multivariate Analysis
2
2018
334
0.170
Why?
Databases, Factual
1
2021
358
0.170
Why?
Azacitidine
1
2019
10
0.160
Why?
Age Factors
3
2016
793
0.160
Why?
Asia
1
2018
10
0.160
Why?
Enzyme Inhibitors
1
2019
120
0.160
Why?
Europe
1
2018
67
0.160
Why?
Appointments and Schedules
1
2018
14
0.160
Why?
Morbidity
1
2018
58
0.160
Why?
Mentors
1
2019
43
0.160
Why?
Arthritis, Experimental
1
2019
48
0.160
Why?
Sex Distribution
1
2018
81
0.160
Why?
Patient Acuity
1
2018
9
0.160
Why?
Workload
1
2018
33
0.150
Why?
Faculty, Medical
1
2019
39
0.150
Why?
Phenotype
4
2012
308
0.150
Why?
Biomedical Research
1
2019
66
0.150
Why?
Risk Assessment
2
2014
676
0.150
Why?
DNA Methylation
1
2019
163
0.150
Why?
Psychiatric Status Rating Scales
1
2018
329
0.150
Why?
Pilot Projects
2
2020
440
0.150
Why?
Interferon Type I
2
2017
12
0.140
Why?
Genome-Wide Association Study
4
2012
291
0.140
Why?
Blood Sedimentation
1
2017
54
0.140
Why?
Philippines
2
2017
4
0.140
Why?
Health Care Surveys
1
2017
66
0.140
Why?
CD11b Antigen
1
2017
15
0.140
Why?
Toll-Like Receptors
1
2017
17
0.140
Why?
Retrospective Studies
2
2018
3612
0.140
Why?
Illinois
1
2017
247
0.130
Why?
Macrophages
1
2017
107
0.130
Why?
Socioeconomic Factors
3
2016
311
0.130
Why?
Health Status Disparities
1
2017
75
0.130
Why?
France
1
2016
18
0.130
Why?
Mental Health
1
2017
123
0.130
Why?
Arthralgia
2
2008
125
0.130
Why?
Sleep Initiation and Maintenance Disorders
1
2017
108
0.130
Why?
Time Factors
2
2017
1497
0.130
Why?
Hong Kong
1
2015
2
0.120
Why?
Magnetic Resonance Imaging
2
2013
1196
0.120
Why?
Interferon Regulatory Factor-7
2
2017
4
0.120
Why?
Software
1
2015
67
0.120
Why?
Self Concept
2
2012
43
0.120
Why?
Cosmetic Techniques
1
2014
5
0.120
Why?
Professional-Patient Relations
1
2015
28
0.120
Why?
Observational Studies as Topic
1
2014
19
0.120
Why?
Double-Blind Method
1
2016
424
0.120
Why?
Critical Pathways
1
2014
21
0.120
Why?
Dose-Response Relationship, Drug
1
2015
349
0.120
Why?
Chi-Square Distribution
1
2014
146
0.120
Why?
Focus Groups
1
2014
93
0.120
Why?
Goals
1
2014
44
0.110
Why?
Sleep
1
2017
355
0.110
Why?
Genetic Variation
2
2011
100
0.110
Why?
Combined Modality Therapy
1
2014
306
0.110
Why?
Interferon Regulatory Factors
1
2013
2
0.110
Why?
Turkey
1
2013
6
0.110
Why?
Promoter Regions, Genetic
2
2011
100
0.110
Why?
Latin America
1
2013
5
0.110
Why?
Disease Management
1
2013
114
0.100
Why?
Matched-Pair Analysis
1
2012
30
0.100
Why?
Self-Assessment
1
2012
30
0.100
Why?
Multiple Sclerosis
1
2013
102
0.100
Why?
Quality Improvement
1
2013
161
0.100
Why?
Feedback
1
2012
33
0.100
Why?
Osteopontin
1
2011
5
0.100
Why?
Ubiquitin-Conjugating Enzymes
1
2011
5
0.100
Why?
Gene Expression Profiling
1
2012
140
0.100
Why?
Sensitivity and Specificity
1
2013
520
0.100
Why?
DEAD-box RNA Helicases
1
2011
5
0.090
Why?
Complementary Therapies
1
2011
8
0.090
Why?
DNA
4
2013
104
0.090
Why?
Genetic Association Studies
1
2011
86
0.090
Why?
Aged, 80 and over
2
2019
4904
0.090
Why?
Alleles
4
2011
213
0.090
Why?
Class III Phosphatidylinositol 3-Kinases
1
2010
1
0.090
Why?
Models, Genetic
1
2010
35
0.090
Why?
Epitopes
1
2010
48
0.090
Why?
Phosphatidylinositol 3-Kinases
1
2010
44
0.090
Why?
Disease Models, Animal
2
2019
628
0.090
Why?
Intracellular Signaling Peptides and Proteins
1
2010
54
0.090
Why?
United Kingdom
1
2010
54
0.080
Why?
Nuclear Proteins
1
2010
86
0.080
Why?
Social Environment
1
2010
84
0.080
Why?
Self-Examination
1
2009
3
0.080
Why?
Follow-Up Studies
1
2014
1868
0.080
Why?
California
3
2017
32
0.080
Why?
Animals
3
2019
3798
0.080
Why?
Cytokines
1
2010
233
0.080
Why?
Educational Status
1
2010
298
0.080
Why?
Analgesics, Non-Narcotic
1
2008
17
0.070
Why?
Biomarkers
1
2011
601
0.070
Why?
Prevalence
2
2011
473
0.070
Why?
Therapeutic Irrigation
1
2007
56
0.070
Why?
Fatal Outcome
1
2007
58
0.070
Why?
Patient Satisfaction
1
2010
329
0.070
Why?
Education, Medical, Undergraduate
1
2007
33
0.070
Why?
Vulva
1
2006
2
0.070
Why?
Data Collection
1
2007
98
0.070
Why?
Injections, Intra-Articular
1
2007
91
0.070
Why?
Joints
1
2007
69
0.070
Why?
Skin Diseases
1
2006
26
0.070
Why?
Cognition
1
2014
1371
0.060
Why?
Disability Evaluation
2
2020
293
0.060
Why?
Hepatitis B
1
2005
12
0.060
Why?
Infliximab
1
2005
17
0.060
Why?
Probability
1
2005
91
0.060
Why?
Genotype
3
2011
352
0.060
Why?
Autoimmune Diseases
2
2019
47
0.060
Why?
Pregnancy Outcome
1
2004
18
0.060
Why?
Sulfasalazine
1
2004
3
0.060
Why?
Lactones
1
2004
9
0.060
Why?
Sulfones
1
2004
20
0.060
Why?
Doxycycline
1
2004
16
0.060
Why?
Methotrexate
1
2004
36
0.060
Why?
Myocardial Infarction
1
2005
141
0.060
Why?
Drug Therapy, Combination
1
2004
184
0.060
Why?
Synovial Fluid
1
2004
95
0.060
Why?
Mice
2
2019
1467
0.050
Why?
Internship and Residency
1
2007
217
0.050
Why?
Osteoarthritis, Knee
1
2008
363
0.050
Why?
Pregnancy
1
2004
340
0.050
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2004
111
0.050
Why?
Prostaglandins A
1
2022
1
0.050
Why?
Republic of Korea
1
2022
6
0.050
Why?
Hypertension
1
2004
226
0.050
Why?
Ribonucleoproteins
2
2011
3
0.050
Why?
Cell Line
2
2012
279
0.050
Why?
Anti-Bacterial Agents
1
2004
376
0.050
Why?
Egypt
1
2020
2
0.040
Why?
Polymorphism, Genetic
2
2011
59
0.040
Why?
Chromatin Immunoprecipitation
1
2019
22
0.040
Why?
Gene Silencing
1
2019
26
0.040
Why?
Anxiety
1
2020
161
0.040
Why?
Flow Cytometry
1
2019
116
0.040
Why?
B-Lymphocytes
1
2019
56
0.040
Why?
Malaria
1
2018
4
0.040
Why?
Immunoglobulin M
1
2018
16
0.040
Why?
Complement C1q
1
2018
7
0.040
Why?
Glucocorticoids
1
2018
70
0.040
Why?
Immunoglobulin G
1
2018
94
0.040
Why?
Georgia
1
2017
11
0.040
Why?
Southeastern United States
1
2017
14
0.040
Why?
Mice, Inbred MRL lpr
1
2017
2
0.040
Why?
Interferon Regulatory Factor-3
1
2017
2
0.040
Why?
Forkhead Box Protein O3
1
2017
5
0.040
Why?
Japan
1
2016
7
0.030
Why?
Australia
1
2016
43
0.030
Why?
Proto-Oncogene Proteins c-akt
1
2017
51
0.030
Why?
Social Class
1
2017
68
0.030
Why?
Registries
1
2017
191
0.030
Why?
Child
1
2020
1423
0.030
Why?
Disabled Persons
1
2016
125
0.030
Why?
Risk Factors
2
2011
2421
0.030
Why?
3' Untranslated Regions
1
2011
5
0.020
Why?
Anemia, Hemolytic
1
2011
4
0.020
Why?
Autoantigens
1
2011
25
0.020
Why?
Thrombocytopenia
1
2011
22
0.020
Why?
Interferon-Induced Helicase, IFIH1
1
2011
1
0.020
Why?
Mexican Americans
1
2011
30
0.020
Why?
Receptors, Lysophosphatidic Acid
1
2010
1
0.020
Why?
Databases, Genetic
1
2010
9
0.020
Why?
Principal Component Analysis
1
2010
26
0.020
Why?
Antibody Specificity
1
2010
35
0.020
Why?
Aminopeptidases
1
2010
7
0.020
Why?
Tumor Necrosis Factor alpha-Induced Protein 3
1
2010
1
0.020
Why?
Protein Structure, Quaternary
1
2010
5
0.020
Why?
Immunoprecipitation
1
2010
24
0.020
Why?
Immunoblotting
1
2010
57
0.020
Why?
Genetic Loci
1
2010
54
0.020
Why?
Interferon-gamma
1
2010
82
0.020
Why?
Transfection
1
2010
121
0.020
Why?
Gene Frequency
1
2010
60
0.020
Why?
Polymerase Chain Reaction
1
2010
117
0.020
Why?
Signal Transduction
1
2011
448
0.020
Why?
Gene Expression Regulation
1
2010
279
0.020
Why?
DNA-Binding Proteins
1
2010
275
0.020
Why?
Algorithms
1
2010
378
0.020
Why?
Knee Joint
1
2008
754
0.010
Why?
Jolly's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (302)
Explore
_
Co-Authors (12)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_